Qualicorp Consultoria e Corretora de Seguros SA
BOVESPA:QUAL3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (1.2), the stock would be worth R$2.33 (20% upside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1 | R$1.95 |
0%
|
| 3-Year Average | 1.2 | R$2.33 |
+20%
|
| 5-Year Average | 2.3 | R$4.25 |
+118%
|
| Industry Average | 4.9 | R$9.33 |
+379%
|
| Country Average | 6.4 | R$12.1 |
+521%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
R$621.8m
|
/ |
Jan 2026
R$580.3m
|
= |
|
|
R$621.8m
|
/ |
Dec 2026
R$542.4m
|
= |
|
|
R$621.8m
|
/ |
Dec 2027
R$577.3m
|
= |
|
|
R$621.8m
|
/ |
Dec 2028
R$579.6m
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| BR |
|
Qualicorp Consultoria e Corretora de Seguros SA
BOVESPA:QUAL3
|
552.1m BRL | 1 | 51.8 | |
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
321.2B USD | 0 | 26.6 | |
| US |
A
|
Anthem Inc
LSE:0HG8
|
88.9B USD | 0 | 15.7 | |
| US |
|
Elevance Health Inc
NYSE:ELV
|
76.4B USD | 0 | 13.5 | |
| US |
|
Humana Inc
NYSE:HUM
|
25.9B USD | 0 | 21.8 | |
| US |
|
Centene Corp
NYSE:CNC
|
20.2B USD | 0 | -3 | |
| US |
|
Molina Healthcare Inc
NYSE:MOH
|
8.9B USD | 4.8 | 18.9 | |
| US |
|
Healthequity Inc
NASDAQ:HQY
|
6.6B USD | 14.9 | 30.7 | |
| US |
M
|
Magellan Health Inc
F:MAH1
|
2.2B EUR | 12.9 | 8.5 | |
| BR |
|
Odontoprev SA
BOVESPA:ODPV3
|
8.4B BRL | 9.6 | 14.2 | |
| US |
|
Progyny Inc
NASDAQ:PGNY
|
1.5B USD | 11.1 | 24.7 |
Market Distribution
| Min | 0.4 |
| 30th Percentile | 5.1 |
| Median | 6.4 |
| 70th Percentile | 9.2 |
| Max | 1 748.1 |
Other Multiples
Qualicorp Consultoria e Corretora de Seguros SA
Glance View
Qualicorp Consultoria e Corretora de Seguros SA, formerly Qualicorp SA, is a Brazil-based company primarily active in the healthcare insurance sector. The Company focuses on administrating and managing healthcare plans, including group health and dental insurance. Its activities are divided into two areas: Affinity and Corporate. The Affinity division offers intermediary services between insurance providers and institutions, as well as additional administrative services, such as monitoring of the medical services used and monthly billing. The Corporate division provides insurance advisory, brokerage, management of outsourced benefits, connectivity and risk to national and international companies, as well as government bodies. The Company operates through a number of subsidiaries, such as Qualicorp Corretora de Seguros SA, Qualicorp Administradora de Beneficios SA and Gama Saude Ltda.
